Concepedia

Generic-to-generic Switching

Generic-To-Generic Switching is a pharmaceutical practice within the broader category of generic substitution, wherein one generic drug product is interchanged with another generic drug product containing the same active ingredient but manufactured by a different company, differing primarily in excipients, dosage form, or bioavailability characteristics while maintaining therapeutic equivalence.

33

Publications

1.5K

Citations

152

Authors

87

Institutions

Publications per year

2017–2026

5

Parents

Publications

33

Compulsory Generic Switching of Antiepileptic Drugs: High Switchback Rates to Branded Compounds Compared with Other Drug Classes

Frédérick Andermann, Mei Sheng Duh, Antoine Gosselin et al. · Epilepsia · 2007 · 178 citations

, , +17

Switching from Originator Brand Medicines to Generic Equivalents in Selected Developing Countries: How Much Could Be Saved?

Alexandra Cameron, Aukje K. Mantel‐Teeuwisse, Hubert G.M. Leufkens et al. · Value in Health · 2012 · 175 citations · Full text

, , +12

Clinical consequences of generic substitution of lamotrigine for patients with epilepsy

Jacques LeLorier, Mei Sheng Duh, Pierre Emmanuel Paradis et al. · Neurology · 2008 · 117 citations

, , +17

Generic-to-generic lamotrigine switches in people with epilepsy: the randomised controlled EQUIGEN trial

Michael Privitera, Timothy E. Welty, Barry E. Gidal et al. · The Lancet Neurology · 2016 · 93 citations

, , +10

Generic Products of Antiepileptic Drugs (AEDs): Is It an Issue?

Meir Bialer · Epilepsia · 2007 · 80 citations · Full text

, , +17

1–5 of 33

Authors

152

  1. PE
    Pierre Emmanuel Paradis

    Group for Research in Decision Analysis, Canada

    3 publications · 373 citations

    3

    h-index

  2. JØ
    Jette Østergaard Rathe

    University of Southern Denmark, Denmark

    3 publications · 52 citations

    3

    h-index

  3. DE
    Dorte Ejg Jarbøl

    University of Southern Denmark, Denmark

    2 publications · 32 citations

    2

    h-index

  4. LM
    Laura Mumoli

    Magna Graecia University, Italy

    2 publications · 79 citations

    2

    h-index

  5. JS
    Jens Søndergaard

    University of Southern Denmark, Denmark

    2 publications · 32 citations

    2

    h-index

1–5 of 152

Institutions

87

  1. Center for Drug Evaluation and Research

    Silver Spring, United States

    4 h-index

    12 publications

    426 citations

  2. United States Food and Drug Administration

    Silver Spring, United States

    3 h-index

    10 publications

    240 citations

  3. University of Wisconsin–Madison

    Madison, United States

    3 h-index

    4 publications

    228 citations

  4. Group for Research in Decision Analysis

    Montreal, Canada

    3 h-index

    18 publications

    1.9K citations

  5. University of Southern Denmark

    Odense, Denmark

    3 h-index

    14 publications

    240 citations

  6. Hebrew University of Jerusalem

    Jerusalem, Israel

    2 h-index

    2 publications

    92 citations

  7. Massachusetts College of Pharmacy and Health Sciences

    Boston, United States

    2 h-index

    2 publications

    42 citations

  8. University of Pennsylvania

    Philadelphia, United States

    2 h-index

    2 publications

    116 citations

1–8 of 87

Venues

  1. PubMed

    Repository · 2 publications · 39 citations

    2

    h-index

  2. Pharmacoepidemiology and Drug Safety

    2 publications · 31 citations

    2

    h-index

  3. Clinical Pharmacology & Therapeutics

    CPT · 2 publications · 69 citations

    2

    h-index

  4. Epilepsia

    2 publications · 258 citations

    2

    h-index

  5. Neurology

    2 publications · 195 citations

    2

    h-index

1–5